Camptosar and Ms contin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Camptosar (irinotecan hydrochloride) and Ms contin (morphine sulfate). Common drug interactions include failure to thrive among females and disease progression among males.

The phase IV clinical study analyzes what interactions people have when they take Camptosar and Ms contin. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Camptosar?

Camptosar has active ingredients of irinotecan hydrochloride. eHealthMe is studying from 7,145 Camptosar users. Check the latest studies of Camptosar.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

53 people who take Camptosar and Ms contin together, and have interactions are studied.

Camptosar and Ms contin drug interactions.

What are the common drug interactions of Camptosar and Ms Contin, by gender? *:

female:

Failure to thrive (inadequate weight gain and physical growth in children)
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Dehydration (dryness resulting from the removal of water)
Hypoxia (low oxygen in tissues)
Pneumonia
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
White blood cell count decreased
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Blood pressure decreased
Cardiac arrest

male:

Disease progression
Pyrexia (fever)
Mucosal inflammation (infection of mucous membrane)
Pulmonary congestion (congestion in the lungs)
Weight decreased
Cheyne-stokes respiration (abnormal pattern of breathing combination of slow and faster)
Confusion
Hypotension (abnormally low blood pressure)
Interstitial lung disease
Melaena (the passage of black, tarry stools)

What are the common drug interactions of Camptosar and Ms Contin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pyrexia (fever)

40-49:

Diarrhoea
Small intestinal obstruction (blockage in small intestine)
Abdominal distension
Abdominal pain
Abdominal pain lower
Asthenia (weakness)
Breath sounds
Chest discomfort
Cough
Death

50-59:

Pulmonary congestion (congestion in the lungs)
Vomiting
Disease progression
Alopecia (absence of hair from areas of the body)
Bacterial infection
Cerebral infarction (less blood supply to brain resulting tissue damage)
Coma (state of unconsciousness lasting more than six hours)
Confusion
Crepitations (noises are produced by the rubbing of parts one against the other)
Cystitis haemorrhagic (blood in the urine and painful voiding)

60+:

Diarrhoea
Nausea (feeling of having an urge to vomit)
Failure to thrive (inadequate weight gain and physical growth in children)
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Blood pressure decreased
Cheyne-stokes respiration (abnormal pattern of breathing combination of slow and faster)
Coma (state of unconsciousness lasting more than six hours)
Hypoxia (low oxygen in tissues)
Interstitial lung disease

What are the existing conditions these people have? *

Small Cell Lung Cancer Stage Unspecified (lung cancer in unknown stage): 11 people, 20.75%
Colon Cancer: 5 people, 9.43%
Gastric Cancer (stomach cancer): 3 people, 5.66%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Camptosar and Ms contin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously